A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)

Status:
Recruiting

Trial end date:
2024-03-01

Target enrollment:

Participant gender:

The purpose of this study is to assess the effect of reldesemtiv versus placebo on functional outcomes in ALS.

Phase 3

Cytokinetics